Clinical Trial: Short-Course Radiotherapy Followed by mFOLFOX6 with Precise Targeted Therapy and PD-1 Inhibition Versus Short-Course Radiotherapy Followed by mFOLFOX6 Alone in High-Risk pMMR/MSS Rectal Adenocarcinoma: A Prospective, Multicenter, Randomized Controlled Phase Ⅲ Study (CRIT Ⅱ Study) (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Short-Course Radiotherapy Followed by mFOLFOX6 with Precise Targeted Therapy and PD-1 Inhibition Versus Short-Course Radiotherapy Followed by mFOLFOX6 Alone in High-Risk pMMR/MSS Rectal Adenocarcinoma: A Prospective, Multicenter, Randomized Controlled Phase Ⅲ Study (CRIT Ⅱ Study)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132933

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: The Sixth Affiliated Hospital , Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334756

Published by HT Digital Content Serv...